Kancera AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 17.5 million compared to SEK 12.01 million a year ago. Basic loss per share from continuing operations was SEK 0.22 compared to SEK 0.21 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.722 SEK | +17.14% | +13.14% | -62.11% |
May. 08 | Kancera AB Announces Executive Changes | CI |
May. 03 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.11% | 19.26M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- KAN Stock
- News Kancera AB
- Kancera AB Reports Earnings Results for the First Quarter Ended March 31, 2023